© 2025 MJH Life Sciences™ , Patient Care Online – Primary Care News and Clinical Resources. All rights reserved.
Sydney Jennings
Articles
Majority of Americans (8 in 10) Support Routine Childhood Vaccine Requirements, According to New Harvard Poll
July 01, 2025
As authorities record data on the largest US measles outbreak in decades, 79% of Americans support school vaccine mandates for children, an encouraging result.
Mayo Clinic AI Tool Allows Rapid, Precise Identification of 9 Types of Dementia From Single Brain Scan
July 01, 2025
The StateViewer clinical decision support system could help expand access to specialist-level insights in clinics that lack neurology expertise, according to researchers.
8 Common Myths About Chronic Back Pain, Plus 8 Facts That Refute Them
July 01, 2025
Back pain is more common in the US than homeownership, but despite the prevalence, myths persist regarding origins, treatment, and prevention. Here are 8 of them.
SDOH May Affect Use of Menopausal Hormone Therapy: Daily Dose
July 01, 2025
Your daily dose of the clinical news you may have missed.
Nonvaccine Seasonal Flu Preventive Shows Promise in Phase 2b Clinical Trial: Cidara Therapeutics
June 30, 2025
CD388, an investigational nonvaccine antiviral, demonstrated efficacy up to 76% against influenza in a cohort of more than 5000 healthy, unvaccinated adults.
Adjuvanted Vaccine Against RSV Associated with Substantial Reduced Risk of Dementia
June 30, 2025
The adjuvanted RSV vaccine, in particular, was associated with a 29% reduction in the risk of dementia in the subsequent 18 months, a University of Oxford study found.
Moderna's mRNA-1010 Flu Vaccine Proves Superior Efficacy in Pivotal Late-Stage Trial
June 30, 2025
The vaccine showed superior relative vaccine efficacy that was 26.6% higher than a licensed standard-dose influenza vaccine, Moderna reported.
Survey Finds People with Atopic Dermatitis Want Better Symptom Relief: Daily Dose
June 30, 2025
Your daily dose of the clinical news you may have missed.
First Patient Receives Lipocene's LPCN 1154 for Postpartum Depression in Phase 3 Clinical Trial
June 27, 2025
Lipocene anticipates the phase 3 trial data will support an NDA submission for LPCN 1154 to treat PPD in mid-2026, the company said.
GLP-1 Drug Prescribing Trends Mirror Rise in US Obesity Rates
June 27, 2025
Obesity treatment evolves as GLP-1 medication use surges 587%, while bariatric surgery rates decline significantly. A new analysis parses the trends.